Trial · NCT00752726
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to Week 24 in Abdominal VAT Mass | Orlistat 60 mg | -0.630 | Standard Deviation 0.6887 | kg | |
| Change From Baseline to Week 24 in Abdominal VAT Mass | Placebo | -0.403 | Standard Deviation 0.7249 | kg | |
| Change From Baseline to Week 12 in Abdominal VAT Mass | Orlistat 60 mg | -0.496 | Standard Deviation 0.4943 | kg | |
| Change From Baseline to Week 12 in Abdominal VAT Mass | Placebo | -0.351 | Standard Deviation 0.5904 | kg | |
| Change From Baseline to Week 24 in Body Weight | Orlistat 60 mg | -5.96 | Standard Deviation 4.743 | kg | |
| Change From Baseline to Week 24 in Body Weight | Placebo | -3.91 | Standard Deviation 5.375 | kg | |
| Change From Baseline to Week 24 in Total Fat Mass | Orlistat 60 mg | -4.69 | Standard Deviation 3.691 | kg | |
| Change From Baseline to Week 24 in Total Fat Mass | Placebo | -3.16 | Standard Deviation 4.248 | kg | |
| Change From Baseline to Week 24 in Percentage Body Fat | Orlistat 60 mg | -1.70 | Standard Deviation 3.434 | Percentage (%) body fat | |
| Change From Baseline to Week 24 in Percentage Body Fat | Placebo | -0.38 | Standard Deviation 4.232 | Percentage (%) body fat | |
| Change From Baseline to Week 24 in Waist Circumference | Orlistat 60 mg | -6.65 | Standard Deviation 0.692 | cm | |
| Change From Baseline to Week 24 in Waist Circumference | Placebo | -4.95 | Standard Deviation 0.704 | cm | |
| Change From Baseline to Week 24 in Percentage Liver Fat | Orlistat 60 mg | -0.0008 | Standard Deviation 0.00609 | Percentage (%) IHL | |
| Change From Baseline to Week 24 in Percentage Liver Fat | Placebo | -0.0112 | Standard Deviation 0.03642 | Percentage (%) IHL | |
| Change From Baseline to Week 24 in Liver Fat | Orlistat 60 mg | 0.06 | Standard Deviation 0.169 | Hounsfield Units (HU) | |
| Change From Baseline to Week 24 in Liver Fat | Placebo | 0.02 | Standard Deviation 0.174 | Hounsfield Units (HU) | |
| Change From Baseline to Week 24 in Total Calories Expended for Physical Activity | Orlistat 60 mg | -498 | Standard Deviation 6627 | Kilocalorie (kcal)/week | |
| Change From Baseline to Week 24 in Total Calories Expended for Physical Activity | Placebo | 517 | Standard Deviation 4873 | Kilocalorie (kcal)/week | |
| Change From Baseline to Week 24 in Quality of Life (QoL) Scores. | Orlistat 60 mg | 5.29 | Standard Deviation 8.009 | Score on a Scale | |
| Change From Baseline to Week 24 in Quality of Life (QoL) Scores. | Placebo | 8.78 | Standard Deviation 10.429 | Score on a Scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00752726/results